|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9567
|
|
pubmed:dateCreated |
2007-4-2
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Epidemiological and clinical evidence suggests that an increased intake of long-chain n-3 fatty acids protects against mortality from coronary artery disease. We aimed to test the hypothesis that long-term use of eicosapentaenoic acid (EPA) is effective for prevention of major coronary events in hypercholesterolaemic patients in Japan who consume a large amount of fish.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
pubmed-author:HishidaHitoshiH,
pubmed-author:IshikawaYuichiY,
pubmed-author:ItakuraHiroshigeH,
pubmed-author:Japan EPA lipid intervention study (JELIS) Investigators,
pubmed-author:KitaToruT,
pubmed-author:KitabatakeAkiraA,
pubmed-author:MatsuzakiMasunoriM,
pubmed-author:MatsuzawaYujiY,
pubmed-author:NakayaNoriakiN,
pubmed-author:OikawaShinichiS,
pubmed-author:OrigasaHidekiH,
pubmed-author:SaitoYasushiY,
pubmed-author:SakataToshiieT,
pubmed-author:SasakiJunJ,
pubmed-author:ShimadaKazuyukiK,
pubmed-author:ShiratoKunioK,
pubmed-author:YokoyamaMitsuhiroM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
31
|
|
pubmed:volume |
369
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1090-8
|
|
pubmed:dateRevised |
2007-10-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17398308-Adult,
pubmed-meshheading:17398308-Aged,
pubmed-meshheading:17398308-Coronary Disease,
pubmed-meshheading:17398308-Diet,
pubmed-meshheading:17398308-Eicosapentaenoic Acid,
pubmed-meshheading:17398308-Female,
pubmed-meshheading:17398308-Humans,
pubmed-meshheading:17398308-Hypercholesterolemia,
pubmed-meshheading:17398308-Japan,
pubmed-meshheading:17398308-Male,
pubmed-meshheading:17398308-Middle Aged
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
|
|
pubmed:affiliation |
Kobe University, Kobe, Japan. yokoyama@med.kobe-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
